Investor Relations

OPKO Announces Second Quarter Operating and Financial Results more »

Rayaldee Phase 3 Trial Meets Primary Endpoints more »

OPKO Submits IND for Rayaldee™ as Adjunctive Cancer Therapy more »

OPKO to Announce Top Line RAYALDEE Results and Second Quarter 2014 Financial Results on August 11, 2014 more »

Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put OPKO Health, Inc.'s financial performance into perspective.

  • Events

Aug 12, 2014 - 8:30 AM ET
Second Quarter 2014 Financial Results
Webcast Listen to webcast

  • Stock Information


Ticker OPK Exchange NYSE
Last Price 8.80 Change 0.02 down
Open 8.84 Previous Close 8.82
Day High 8.85 Day Low 8.75
52-Week High 12.95 52-Week Low 7.32
Quotes delayed at least 20 minutes. Information provided by eSignal.